Back to results
US 2023/0405103 A1Published application
Coxiella burnetii avirulent nine mile phase ii viable bacteria and methods of use
AssigneeBoard of Regents, The University of Texas System
InventorGuoquan F. Zhang
Life of this patent
Estimating the term…
Abstract
Certain embodiments are directed to the use of avirulent LPS phase II viable bacteria as a live attenuated vaccine against human Q fever and method of immunizing a subject with said vaccine.
Claims4
A Q fever vaccine comprising a live avirulent Coxiella burnetii (C. burnetii) strain having a phase II LPS phenotype.
Dependencies are inferred from the claim text.